Table of Contents Author Guidelines Submit a Manuscript
Volume 5, Pages 151-154
Directions in Science

Natural Cytotoxicity Receptors: Pattern Recognition and Involvement of Carbohydrates

Department of Microbiology and Immunology, Faculty of Health Sciences and Cancer Research Center, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel

Received 5 January 2005; Revised 30 January 2005; Accepted 2 February 2005

Copyright © 2005 Angel Porgador.

Citations to this Article [12 citations]

The following is the list of published articles that have cited the current article.

  • Alon Zilka, Guy Landau, Noga Bloushtain, Eyal Fima, John T. Gallagher, Sharona Elgavish, Oren Hershkovitz, Ahuva Bar-Ilan, Fabrice Benchetrit, Toin H. Van Kuppevelt, and Angel Porgador, “Characterization of the heparin/heparan sulfate binding site of the natural cytotoxicity receptor NKp46,” Biochemistry, vol. 44, no. 44, pp. 14477–14485, 2005. View at Publisher · View at Google Scholar
  • Oren Hershkovitz, Sergey Jivov, Noga Bloushtain, Alon Zilka, Guy Landau, Ahuva Bar-Ilan, Rachel G. Lichtenstein, Kerry S. Campbell, Toin H. van Kuppevelt, and Angel Porgador, “Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44,” Biochemistry, vol. 46, no. 25, pp. 7426–7436, 2007. View at Publisher · View at Google Scholar
  • Ahuva Bar-Ilan, Eyal Fima, Ruth Galili, Daniel Benharroch, Ofer Mandelboim, Tal I. Arnon, Gal Markel, Jacob Hanna, Fabrice Benchetrit, Adelheid Cerwenka, Netta Sion-Vardy, and Angel Porgador, “Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy,” PLoS ONE, vol. 3, no. 5, 2008. View at Publisher · View at Google Scholar
  • Oren Hershkovitz, Benyamin Rosental, Martha Erika Navarro-Sanchez, Orly Gershoni-Yahalom, Elodie Brient-Litzler, Bracha Rager-Zisman, Angel Porgador, Lior Ann Rosenberg, Sergey Jivov, Alon Zilka, Hugues Bedouelle, Joanna W. Ho, Kerry S. Campbell, and Philippe Despres, “NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells,” Journal of Immunology, vol. 183, no. 4, pp. 2610–2621, 2009. View at Publisher · View at Google Scholar
  • Yoram Tekoah, Alon Zilka, Orly Gershoni-Yahalom, Michal Mandelboim, Angel Porgador, Michal Mendelson, Roi Gazit, Hagit Achdout, Nicolai V. Bovin, Tal Meningher, Ofer Mandelboim, and Ayelet David, “NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus,” Journal of Virology, vol. 84, no. 8, pp. 3789–3797, 2010. View at Publisher · View at Google Scholar
  • Michael Brusilovsky, Benyamin Rosental, Avishai Shemesh, Michael Y. Appel, and Angel Porgador, “Human NK cell recognition of target cells in the prism of natural cytotoxicity receptors and their ligands,” Journal of Immunotoxicology, vol. 9, no. 3, pp. 267–274, 2012. View at Publisher · View at Google Scholar
  • Agata Białoszewska, Florence Baychelier, Justyna Niderla-Bielińska, Andrzej Czop, Patrice Debré, Vincent Vieillard, Claudine Kieda, and Jacek Malejczyk, “Constitutive expression of ligand for natural killer cell NKp44 receptor (NKp44L) by normal human articular chondrocytes,” Cellular Immunology, 2013. View at Publisher · View at Google Scholar
  • Behjatolah Monzavi-Karbassi, Anastas Pashov, and Thomas Kieber-Emmons, “Tumor-Associated Glycans and Immune Surveillance,” Vaccines, vol. 1, no. 2, pp. 174–203, 2013. View at Publisher · View at Google Scholar
  • Tal Goldberger, and Ofer Mandelboim, “The use of microRNA by human viruses: lessons from NK cells and HCMV infection,” Seminars in Immunopathology, 2014. View at Publisher · View at Google Scholar
  • Paul E. Leon, Wenqian He, Caitlin E. Mullarkey, Mark J. Bailey, Matthew S. Miller, Florian Krammer, Peter Palese, and Gene S. Tan, “Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact,” Proceedings of the National Academy of Sciences, pp. 201613225, 2016. View at Publisher · View at Google Scholar
  • Yonat Shemer-Avni, Kiran Kundu, Avishai Shemesh, Michael Brusilovsky, Rami Yossef, Mesfin Meshesha, Semaria Solomon-Alemayehu, Shai Levin, Orly Gershoni-Yahalom, Kerry S. Campbell, and Angel Porgador, “Expression of NKp46 Splice Variants in Nasal Lavage Following Respiratory Viral Infection: Domain 1-Negative Isoforms Predominate and Manifest Higher Activity,” Frontiers in Immunology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Archana Thakur, Manley Huang, and Lawrence G. Lum, “Bispecific antibody based therapeutics: Strengths and challenges,” Blood Reviews, 2018. View at Publisher · View at Google Scholar